We are live on ! Find out more
RTC

Riverview Trust Company Portfolio holdings

AUM $81.2M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
+7.14%
1 Year Est. Return
+18.57%
3 Year Est. Return
+67.64%
5 Year Est. Return
+74.55%
10 Year Est. Return
AUM
$114M
AUM Growth
+$8.51M
Cap. Flow
+$1.89M
Cap. Flow %
1.66%
Top 10 Hldgs %
36.42%
Holding
859
New
235
Increased
290
Reduced
79
Closed
38

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$88.8K
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$75.5K
3
BMY icon
Bristol-Myers Squibb
BMY
+$59.3K
4
JNJ icon
Johnson & Johnson
JNJ
+$53.9K
5
DIOD icon
Diodes
DIOD
+$51.6K

Sector Composition

Rank Sector Weight
1 Technology 20.98%
2 Healthcare 10.2%
3 Financials 9.34%
4 Communication Services 6.06%
5 Consumer Discretionary 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTNX icon
776
Nutanix
NTNX
$16B
$533 ﹤0.01%
+9
New +$494
FTAI icon
777
FTAI Aviation
FTAI
$21.1B
$532 ﹤0.01%
+4
New +$453
RXO icon
778
RXO
RXO
$3.34B
$532 ﹤0.01%
+19
New +$537
PRIM icon
779
Primoris Services
PRIM
$4.58B
$523 ﹤0.01%
+9
New +$480
LQDA icon
780
Liquidia Corp
LQDA
$7.48B
$520 ﹤0.01%
+52
New +$568
JBHT icon
781
JB Hunt Transport Services
JBHT
$25.5B
$517 ﹤0.01%
+3
New +$504
QRVO icon
782
Qorvo
QRVO
$7.99B
$517 ﹤0.01%
+5
New +$562
CPNG icon
783
Coupang
CPNG
$29.3B
$516 ﹤0.01%
+21
New +$467
SGRY icon
784
Surgery Partners
SGRY
$2.01B
$516 ﹤0.01%
+16
New +$473
IDA icon
785
Idacorp
IDA
$8.27B
$515 ﹤0.01%
+5
New +$499
PATH icon
786
UiPath
PATH
$6.61B
$512 ﹤0.01%
40
-1,029
-96% -$12.6K
ITCI
787
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$512 ﹤0.01%
+7
New +$526
NTRA icon
788
Natera
NTRA
$38.3B
$508 ﹤0.01%
+4
New +$459
AVNT icon
789
Avient
AVNT
$3.33B
$503 ﹤0.01%
+10
New +$459
THC icon
790
Tenet Healthcare
THC
$20.5B
$499 ﹤0.01%
+3
New +$454
RRX icon
791
Regal Rexnord
RRX
$13.7B
$498 ﹤0.01%
+3
New +$463
BHF icon
792
Brighthouse Financial
BHF
$3.56B
$495 ﹤0.01%
+11
New +$494
IBP icon
793
Installed Building Products
IBP
$6.01B
$493 ﹤0.01%
+2
New +$453
BMRN icon
794
BioMarin Pharmaceuticals
BMRN
$11.6B
$492 ﹤0.01%
7
-204
-97% -$17.1K
TMHC
795
DELISTED
Taylor Morrison
TMHC
$492 ﹤0.01%
+7
New +$448
WSO icon
796
Watsco Inc
WSO
$12.7B
$492 ﹤0.01%
+1
New +$481
HQY icon
797
HealthEquity
HQY
$8.41B
$491 ﹤0.01%
+6
New +$463
SGI
798
Somnigroup International
SGI
$13.7B
$491 ﹤0.01%
+9
New +$457
AGIO icon
799
Agios Pharmaceuticals
AGIO
$1.79B
$489 ﹤0.01%
+11
New +$500
RITM icon
800
Rithm Capital
RITM
$5.52B
$488 ﹤0.01%
+43
New +$489

Similar funds

Riverview Trust Company's Q3 2024 Portfolio in Review

As of Q3 2024, Riverview Trust Company held 859 positions worth $114M, up 8.1% from $106M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Riverview Trust Company's Q3 2024 filing shows 235 new, 290 increased, 79 reduced and 38 closed positions. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 6,543 shares worth $463K. The largest sale was Intel, an estimated $88.8K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Riverview Trust Company's largest Q3 2024 buy was iShares Core MSCI International Developed Markets ETF: 6,543 shares worth $463K.
  • Riverview Trust Company added most to Vanguard Morningstar Total Stock Market ETF in Q3 2024, an estimated $502K increase.
  • Riverview Trust Company's biggest Q3 2024 reduction was Intel, cutting an estimated $88.8K.
  • Riverview Trust Company fully exited Diodes in Q3 2024, selling an estimated $51.6K.
  • Riverview Trust Company's ten largest holdings make up 36% of its $114M portfolio in Q3 2024.
  • Riverview Trust Company opened 235 new positions and closed 38 in Q3 2024.
  • Riverview Trust Company's portfolio value rose 8.1% quarter-over-quarter to $114M.

Based on Riverview Trust Company's 13F filing for Q3 2024, filed 18 Oct 2024.